NAD backs Alzheimer's research-based supplement brain claims

By Shane Starling

- Last updated on GMT

Related tags Vitamin

“Naturally helps improve and maintain short-term memory” is a substantiated claim for GreatMind, rules NAD
“Naturally helps improve and maintain short-term memory” is a substantiated claim for GreatMind, rules NAD
The National Advertising Division (NAD) of the Council of Better Business Bureaus has backed brain claims for a dietary supplement based on studies focused on Alzheimer’s disease.

NAD found Pharmavite’s Nature Made GreatMind possessed sufficient scientific backing to make claims such as “Enhances mental clarity and performance”; “Helps guard against normal cognitive decline associated with aging” and “Naturally helps improve and maintain short-term memory”.

The claims appear online and in labelling for the product that contains vitamin E, folic acid, vitamin B12, N-acetyl-L-cysteine (NAC), acetyl-L-carnitine hydrochloride (ALCAR) and S-adenosylmethionine (SAM-e).

The formulation had been used in three studies conducted by Thomas Shea, PhD, at the University of Massachusetts although with 12mcg doses of B12 rather than the 6mcg contained in GreatMind.

Subjects with early, moderate and later-stage Alzheimer’s disease were used.

“Following its review of the evidence in the record, NAD concluded that the results of the Shea Studies, which found statistically significant improvement in various measures of cognitive ability in those participants taking GreatMind, provided a reasonable basis for the specific claims about the supplement’s ability to improve and maintain memory and cognitive ability,”​ NAD concluded.

It added: “Those subjects showed improvement on certain cognitive and dementia rating scales, and formulation was then later studied in healthy subjects using cognitive scales to evaluate the effects.”

Shea’s studies included a double-blind study, with 93 participants; a six-month trial with the 38 subjects and no control and a two-week study with 43 subjects that compared treatment with the nutraceutical formulation to placebo.

The biggest study involved 18 to 80-year-olds with no known or suspected dementia or clinical memory difficulties, with control and treatment groups given either placebo or GreatMind at different times over a 12-month period.

“Pharmavite believes consumers are best served when advertisers are held to the rigorous standards employed by NAD and appreciates the opportunity to participate in the self-regulatory process,”​ Pharmavite said.

Related news

Show more

Related products

show more

Formulate for women’s health – formulate empowerment

Formulate for women’s health – formulate empowerment

Content provided by Verdure Sciences | 26-Mar-2024 | Product Brochure

Women’s health trends are mirroring bigger conversations of empowerment and wellbeing. Within the women’s health category, upticks in areas of lean muscle...

LocVita® D3: Tailored Formulas & Beadlet Solutions

LocVita® D3: Tailored Formulas & Beadlet Solutions

Content provided by INNOBIO Corporation Limited | 11-Mar-2024 | White Paper

LocVita® Vegan Vitamin D3 delivers specially formulated options that are sugar-free and organic, designed to accommodate various dietary preferences and...

Go Beyond the Ordinary: Cognitive Health-BacoMind

Go Beyond the Ordinary: Cognitive Health-BacoMind

Content provided by Natural Remedies Private Limited | 27-Feb-2024 | White Paper

Experience the potency of BacoMind®, the #1 branded bacopa with 9 key bioactives for unparalleled cognitive support.

Related suppliers

2 comments

3 separate studies

Posted by Thomas B Shea,

Mr. Sardi, while I am unable to comment on the NAD itself, there are 3 separate, published, peer-reviewed studies, two of which included individuals diagnosed with Alzheimer's disease. The third study, detailed above, included 93 participants from 18-80 years of age with no known or suspected dementia. There was no attempt to link that study to anything to do with dementia. (Yes, by the way, college students did improve in this study, but they need to take the formulation at least a couple of weeks, not just the night before the test!) Anyone can email me at thomas_shea@uml.edu and i will forward copies of the published reports.

Report abuse

Is science to be judged by an advertising judge?

Posted by Bill Sardi,

This is the worst of scenarios. An advertising referee is judging science. The charlatans will rule! 18-year olds don't have dementia, so how does this claim pretend to address that age group? Shall 20-year olds take this pill before taking tests in college? God help us all. The NAD put their blessing on a resveratrol pill and didn't make the manufacturer reveal its science that claimed their product was superior to others. The NAD is a tarnished outfit.

Report abuse

Follow us

Products

View more

Webinars